[go: up one dir, main page]

BR9915822A - Derivados de pirazolopirimidinona para o tratamento de impotência - Google Patents

Derivados de pirazolopirimidinona para o tratamento de impotência

Info

Publication number
BR9915822A
BR9915822A BR9915822-1A BR9915822A BR9915822A BR 9915822 A BR9915822 A BR 9915822A BR 9915822 A BR9915822 A BR 9915822A BR 9915822 A BR9915822 A BR 9915822A
Authority
BR
Brazil
Prior art keywords
impotence
treatment
derivatives
pyrazolopyrimidinone derivatives
pyrazolopyrimidinone
Prior art date
Application number
BR9915822-1A
Other languages
English (en)
Other versions
BR9915822B1 (pt
BRPI9915822B8 (pt
Inventor
Moohi Yoo
Wonbae Kim
Min Sun Chang
Joong In Lim
Dong Sung Kim
Yk Yon Kim
Tae Kyun Lim
Byoung Ok Ahn
Kyung Koo Kang
Miwon Son
Hyounmie Doh
Soonhoe Kim
Hyunjoo Shim
Taeyoung Oh
Heungjae Kim
Dong Goo Kim
Original Assignee
Dong A Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27349839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9915822(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd
Publication of BR9915822A publication Critical patent/BR9915822A/pt
Publication of BR9915822B1 publication Critical patent/BR9915822B1/pt
Publication of BRPI9915822B8 publication Critical patent/BRPI9915822B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente Invenção: <B>''DERIVADOS DE PIRAZOLOPIRIMIDINONA PARA O TRATAMENTO DE IMPOTêNCIA''<D>. A presente invenção refere-se a derivados de pirazolopirimidinona de fórmula 1, seu método de preparação e composições farmacêuticas contendo os ditos derivados. Os compostos têm eficácia no tratamento de impotência, uma das disfunções sexuais do macho com os efeitos colaterais reduzidos.
BRPI9915822A 1998-11-11 1999-11-10 derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência BRPI9915822B8 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR19980048100 1998-11-11
KR19990014972 1999-04-27
KR19990049384A KR100353014B1 (ko) 1998-11-11 1999-11-09 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
PCT/KR1999/000675 WO2000027848A1 (en) 1998-11-11 1999-11-10 Pyrazolopyrimidinone derivatives for the treatment of impotence

Publications (3)

Publication Number Publication Date
BR9915822A true BR9915822A (pt) 2001-08-14
BR9915822B1 BR9915822B1 (pt) 2013-08-27
BRPI9915822B8 BRPI9915822B8 (pt) 2021-05-25

Family

ID=27349839

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9915822A BRPI9915822B8 (pt) 1998-11-11 1999-11-10 derivados de pirazolopirimidinona e sua composição farmacêutica para o tratamento de impotência

Country Status (17)

Country Link
US (1) US6583147B1 (pt)
EP (1) EP1129093B1 (pt)
JP (1) JP3577630B2 (pt)
KR (1) KR100353014B1 (pt)
CN (1) CN1136219C (pt)
AT (1) ATE245650T1 (pt)
AU (1) AU760422B2 (pt)
BR (1) BRPI9915822B8 (pt)
CA (1) CA2350538C (pt)
DE (1) DE69909818T2 (pt)
DK (1) DK1129093T3 (pt)
ES (1) ES2204169T3 (pt)
HK (1) HK1039328B (pt)
NZ (1) NZ511015A (pt)
PT (1) PT1129093E (pt)
TR (1) TR200101335T2 (pt)
WO (1) WO2000027848A1 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE414529T1 (de) * 1999-06-23 2008-12-15 Pasteur Institut Zusammensetzungen zur behandlung von beeinträchtigten zwischenmenschlischen störungen und verhaltenstörungen
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
KR100377782B1 (ko) * 2000-06-23 2003-03-29 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논화합물의 제조방법
ES2294189T3 (es) * 2001-12-13 2008-04-01 Asubio Pharma Co., Ltd. Derivados de pirazolopirimidinona que tienen accion inhibidora de pde7.
PT1572173E (pt) 2002-12-13 2010-05-10 Warner Lambert Co Ligando alfa-2-delta para tratar sintomas do tracto urinário inferior
MXPA05009242A (es) * 2003-03-17 2006-04-18 Pfizer Prod Inc Tratamiento de la diabetes tipo 1 con los inhibidores de la pde5.
CN100374441C (zh) 2003-06-06 2008-03-12 天津倍方科技发展有限公司 二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途
WO2005079808A1 (en) 2004-01-22 2005-09-01 Pfizer Limited Triazole derivatives which inhibit vasopressin antagonistic activity
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
EP1850853A4 (en) * 2005-02-18 2011-09-07 Surface Logix Inc PHARMACOKINETICALLY IMPROVED COMPOUNDS
NZ560962A (en) * 2005-02-18 2011-12-22 Surface Logix Inc Methods of making pharmacokinetically improved compounds using sarcosine functional residues or groups and pharmaceutical compositions comprising said compounds
EP2366393B1 (en) 2005-04-19 2013-08-07 Takeda GmbH Roflumilast for the treatment of pulmonary hypertension
US8796286B2 (en) * 2005-06-10 2014-08-05 Mezzion Pharma Co., Ltd. Agent for treatment of liver diseases containing pyrazolopyrimidinone derivative
CN1966506A (zh) * 2005-11-17 2007-05-23 上海特化医药科技有限公司 吡唑并嘧啶酮衍生物及其制备方法和用途
NZ571673A (en) * 2006-04-04 2011-08-26 Dong A Pharm Co Ltd A pyrazolopyrimidinone derivative for the prevention and treatment of prostatic hyperplasia
WO2007141805A2 (en) * 2006-06-05 2007-12-13 Matrix Laboratories Limited Novel process for the preparation of sildenafil citrate
AR062501A1 (es) 2006-08-29 2008-11-12 Actelion Pharmaceuticals Ltd Composiciones terapeuticas
BRPI0716134A2 (pt) 2006-09-07 2013-09-17 Nycomed Gmbh tratamento de combinaÇço para diabetes mellitus
US20090197899A1 (en) * 2006-10-20 2009-08-06 Concert Pharmaceuticals Inc. 3-(Dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide Derivatives and Methods of Use
US20090270425A1 (en) * 2006-10-20 2009-10-29 Concert Pharmaceuticals Inc. 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
EP2089392A4 (en) 2006-10-20 2010-05-05 Concert Pharmaceuticals Inc 3- (DIHYDRO-1H-PYRAZOLO Ý4,3-D¨PYRIMIDIN-5-YL) -4-PROPOXYBENZENESULFONAMIDE DERIVATIVES AND METHODS OF USE
US20080194529A1 (en) * 2007-02-12 2008-08-14 Auspex Pharmaceuticals, Inc. HIGHLY SELECTIVE and LONG-ACTING PDE5 MODULATORS
JP5250026B2 (ja) 2007-05-25 2013-07-31 イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ ヒダントインで修飾したメラノコルチン受容体リガンド
WO2008149345A2 (en) 2007-06-04 2008-12-11 Ben-Gurion University Of The Negev Research And Development Authority Tri-aryl compounds and compositions comprising the same
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
CN101815520A (zh) * 2007-10-02 2010-08-25 东亚制药株式会社 治疗或预防良性前列腺增生和下尿路症状的组合物和方法
KR100920125B1 (ko) * 2007-10-02 2009-10-01 동아제약주식회사 양성 전립선 비대증 치료를 위한 피라졸로피리미디논화합물 및 알파 아드레날린성 수용체 길항제를 함유하는약제학적 배합물
WO2009099620A1 (en) * 2008-02-04 2009-08-13 Concert Pharmaceuticals Inc. 3-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
KR20090087795A (ko) * 2008-02-13 2009-08-18 한양대학교 산학협력단 혈관 재협착 예방 및 치료를 위한 약학 조성물 및 이를포함하는 스텐트
KR101071877B1 (ko) * 2009-02-18 2011-10-10 동아제약주식회사 유데나필 산부가염, 그의 제조방법 및 이를 포함하는 약학적 조성물
GB0903493D0 (en) 2009-02-27 2009-04-08 Vantia Ltd New compounds
EP2556820A4 (en) 2010-04-05 2015-01-21 Sk Chemicals Co Ltd COMPOSITION CONTAINING PDE5 INHIBITOR FOR MITIGATION OF SKIN WRINKLES
CN102952138B (zh) 2011-08-17 2016-07-06 上海特化医药科技有限公司 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用
CA2864322C (en) 2012-02-28 2016-08-09 Seoul Pharma. Co., Ltd. High-content fast dissolving film with masking of bitter taste comprising sildenafil as active ingredient
KR101953735B1 (ko) 2012-12-14 2019-03-04 한미약품 주식회사 포스포다이에스터라제-5 억제제를 포함하는 츄정
CN106061940A (zh) 2013-11-05 2016-10-26 本古里安大学内盖夫研究发展局 治疗糖尿病和由其引发的并发疾病的化合物
MY200278A (en) * 2014-08-12 2023-12-18 Mezzion Pharma Co Ltd Methods of improving exercise capacity in fontan patients using udenafil compositions
KR101645652B1 (ko) 2014-11-03 2016-08-08 (주)퓨젠바이오농업회사법인 세리포리아 락세라타에 의해 생산되는 세포외다당체를 유효성분으로 함유하는 성기능개선용 조성물
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法
KR102249155B1 (ko) * 2019-07-26 2021-05-07 주식회사 코아팜바이오 유데나필을 함유하는 약제학적 조성물
CN113493459B (zh) * 2020-04-07 2022-12-13 广州白云山医药集团股份有限公司白云山制药总厂 Pde5抑制剂化合物及其制备方法和应用
JP7769648B2 (ja) * 2020-06-19 2025-11-13 アナシス・ファルマ・プロプライエタリー・リミテッド スルホンアミド化合物
US11787812B2 (en) * 2020-12-11 2023-10-17 Ildong Pharmaceutical Co., Ltd. Substituted pyrazolo[4,3-d]pyrimidines and imidazo[5,1 -f][1,2,4]triazines as androgen receptor and phosphodiesterase dual inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9119704D0 (en) * 1991-09-14 1991-10-30 Pfizer Ltd Therapeutic agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
KR100390612B1 (ko) * 1997-04-25 2003-07-07 화이자 인코포레이티드 타입 5 시클릭 구아노신 3',5'-모노포스페이트포스포디에스테라제를 억제하는 성기능 장애 치료용피라졸로피리미디논 제조용 중간체의 제조 방법
KR100297814B1 (ko) * 1998-12-29 2001-10-26 조민호 피라졸로피리미디논유도체와이의제조방법그리고이의용도

Also Published As

Publication number Publication date
CN1136219C (zh) 2004-01-28
US6583147B1 (en) 2003-06-24
ATE245650T1 (de) 2003-08-15
KR20000035324A (ko) 2000-06-26
CN1325398A (zh) 2001-12-05
BR9915822B1 (pt) 2013-08-27
ES2204169T3 (es) 2004-04-16
DE69909818T2 (de) 2004-05-27
EP1129093B1 (en) 2003-07-23
KR100353014B1 (ko) 2002-09-18
EP1129093A1 (en) 2001-09-05
WO2000027848A1 (en) 2000-05-18
DE69909818D1 (de) 2003-08-28
JP3577630B2 (ja) 2004-10-13
NZ511015A (en) 2003-09-26
JP2002529467A (ja) 2002-09-10
HK1039328B (zh) 2004-06-25
BRPI9915822B8 (pt) 2021-05-25
PT1129093E (pt) 2003-12-31
AU760422B2 (en) 2003-05-15
AU1081700A (en) 2000-05-29
CA2350538C (en) 2005-06-28
DK1129093T3 (da) 2003-10-20
HK1039328A1 (en) 2002-04-19
TR200101335T2 (tr) 2001-09-21
CA2350538A1 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
BR9915822A (pt) Derivados de pirazolopirimidinona para o tratamento de impotência
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE231839T1 (de) Polyaromatische antivirale zusammensetzungen
BRPI0415179A (pt) derivados de amida como ligandos de canal de ìon e composições farmacêuticas e métodos de empregar as mesmas
BR9911060A (pt) Composições compreendendo mono- ou dinitrato orgânico para tratar impotência
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
CU23088A3 (es) Compuestos de tetra-hidropiridina.
DK1109814T3 (da) 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion
DE59909607D1 (de) Tan-1057 derivate
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
BR0309996A (pt) Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
NO970178D0 (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
IL135634A0 (en) 5-htif agonists
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
BG105549A (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
BR0214644A (pt) Uso de derivados de ácido 4-oxobutanóico no tratamento de inflamação
NO20010624D0 (no) N-substituerte azacykloheptanderivater, fremstilling og anvendelse derav
GB9926301D0 (en) Novel compounds

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]

Free format text: REF. AO DESPACHO 9.1 DA RPI 2147 DE 28/02/2012 POR TER SIDO EFETUADO COM O TITULO INCORRETO

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/08/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 10/11/1999 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 10/11/2019